Precise Automation (Brooks)

the PreciseFlex compact robot platform is positioned for intelligent lab automation, addressing lab-automation failure modes such as misaligned plates and incorrect consumable placement in drug-discovery workflows.

Country
United States
Ticker
NASDAQ:BRKS
Commercial
Coverage
CNEUUS
analytics-pat✓✓✓
Regulatorsfdaemanmpa

Verifiable facts

FactValueSource
Funding$250,000 in a single seed funding round on July 23, 2009thecompanycheck.com
Capacitythousands of robots a year at the Livermore, CA facilitymanuals.brooks.com
CertificationISO 9001:2015 certification held by Brooks Automation US, LLCmanuals.brooks.com
Production siteFremont, CA (headquarters/site) and Livermore, CA (manufacturing facility)manuals.brooks.com · prnewswire.com · thecompanycheck.com
Headcount16 employees as of May 31, 2026; 2 employees as of April 30, 2022thecompanycheck.com
Revenue$17 million in revenue for the 12 months preceding April 2021 acquisitionprnewswire.com

Independent sources: manuals.brooks.com · prnewswire.com · thecompanycheck.com

Technologies
NameClusterRisk
Cobots for bioproductionanalytics-patLow→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.